Hms Holdings Corp (HMSY) Gets a Hold Rating from Cantor Fitzgerald


In a report released yesterday, Steven Halper from Cantor Fitzgerald reiterated a Hold rating on Hms Holdings Corp (HMSY), with a price target of $31. The company’s shares closed on Friday at $34.09, close to its 52-week high of $35.94.

Halper observed:

“. We reiterate our Neutral rating on HMSY shares and increase our 12-month price target to $31 from $26. On November 2, HMSY reported strong 3Q18 results. HMSY revenue benefited somewhat from a pull forward from 4Q18. The company’s solid cost management boosted margins and the bottom line (also aided by a tax benefit in the quarter). Performance improved across the company’s business segments, with Payment Integrity (PI) achieving the highest top- line growth. PI performance has improved nicely in recent quarters. Management raised its 2018 revenue guidance in light of the strong quarter.”

According to TipRanks.com, Halper is a top 25 analyst with an average return of 21.3% and a 70.3% success rate. Halper covers the Services sector, focusing on stocks such as WellCare Health Plans, Evolent Health, and Centene Corp.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Hms Holdings Corp with a $30.17 average price target.

See today’s analyst top recommended stocks >>

Hms Holdings Corp’s market cap is currently $2.84B and has a P/E ratio of 85.22. The company has a Price to Book ratio of 4.60.

Based on the recent corporate insider activity of 54 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of HMSY in relation to earlier this year. Most recently, in September 2018, William F. Miller, a Director at HMSY bought 2,554 shares for a total of $58,614.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

HMS Holdings Corp. engages in the provision of cost containment solutions in the healthcare marketplace. The firm operates through its wholly owned subsidiaries, Health Management Systems, Inc. HealthDataInsights, Inc., HMS Care Analytics, Inc., IntegriGuard, LLC, and Reimbursement Services Group Inc..

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts